Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, Par Value $0.0001 Per Share
-
Shares outstanding
-
23,267,064
-
Total 13F shares
-
1,527,086
-
Share change
-
+194,265
-
Total reported value
-
$23,515,000
-
Price per share
-
$15.40
-
Number of holders
-
23
-
Value change
-
+$2,997,259
-
Number of buys
-
14
-
Number of sells
-
3
Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) as of Q1 2017
As of 31 Mar 2017,
MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,527,086 shares.
The largest 10 holders included
Capital World Investors, ADAGE CAPITAL PARTNERS GP, L.L.C., Rock Springs Capital Management LP, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BAKER BROS. ADVISORS LP, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and GOLDMAN SACHS GROUP INC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.